Physiologically based pharmacokinetic (PBPK) modelling of cabotegravir (CAB) to support design of microarray patches (MAPs) for the treatment of HIV positive children

PBPK & PBBM

Infectious Diseases

Eriksson J, Sjögren E, Pellowe M, Choy RKM, Mistilis J, Jarrahian C, Zehrung D, Vora LK, Volpe-Zanutto F, Tekko IA, Donnelly RF, Chenel M